[1]
“Formulation and Evaluation of Gliclazide Solid Dispersions Incorporated Tablets for Controlled Drug Release”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 6, pp. 621–629, Nov. 2020, doi: 10.25004/IJPSDR.2020.120606.